+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Valine Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 320 Pages
  • August 2024
  • Region: Global
  • Allied Market Research
  • ID: 6054196
The valine market was valued at $323.1 million in 2023, and is projected to reach $423.6 million by 2033, growing at a CAGR of 2.8% from 2024 to 2033.

Valine is a branched-chain essential amino acids that cannot be synthesized in the body and must be obtained through diet. Valine is particularly important for stimulating muscle growth, tissue repair, and providing energy during physical activity. It is also involved in maintaining nitrogen balance in the body and supports cognitive function and emotional stability. Valine-rich foods include dairy products, meats, soy, and legumes.

The growth of the global valine market is driven by surge in demand for dietary supplements. As awareness about health and fitness grows, consumers are increasingly turning to amino acid supplements like valine for muscle recovery, endurance, and overall performance, especially among athletes and fitness enthusiasts. A study published in 2021 by the International Society of Sports Nutrition highlighted that branched-chain amino acid supplements, which include valine, are consumed by 37% of athletes to enhance performance, muscle recovery, and reduce muscle fatigue. In addition, expansion of the animal feed industry notably contributes toward the market growth.

This is attributed to the fact that valine is an essential component of animal feed formulations, particularly in poultry and swine farming, where it supports growth, protein synthesis, and improves feed efficiency, driving its demand in the agricultural sector. Moreover, rise in prevalence of chronic diseases acts as the key driving force of the global market. The therapeutic role of valine in managing muscle-wasting conditions, liver disorders, and neurological diseases is boosting its use in medical and pharmaceutical applications. According to the 2023 study published by the World Health Organization, approximately 41 million individuals die each year due to chronic diseases.

Furthermore, as more consumers shift toward plant-based diets, there is an increasing demand for plant-derived amino acids, including valine, in alternative protein products and supplements, thereby augmenting the market growth. However, the overall cost of producing high-purity valine, especially through synthetic and fermentation processes, remains significant, limiting accessibility for small-scale manufacturers.

Moreover, availability of other essential amino acids, such as leucine and isoleucine, which are also part of the branched-chain amino acids, play a significant role in muscle synthesis and recovery, thus limiting the demand for valine. On the contrary, improved production processes, such as fermentation techniques, have lowered manufacturing costs and increased the supply of high-purity valine. Such developments are expected to offer remunerative opportunities for the expansion of the valine market during the forecast period.

The valine market is segmented into type, end-use industry, and region. By type, the market is classified into D-valine, and L-valine. As per the end-use industry, it is categorized into feed industry, food industry, pharmaceutical industry, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the L-valine segment emerged as the dominant force in the valine market in 2023.

On the basis of end-use industry, the feed industry segment dominated the market in 2023.

Region wise, Asia-Pacific was the most lucrative market for valine in 2023.

Competition Analysis

Competitive analysis and profiles of the major players in the global valine market include Ajinomoto Co., Inc., Foodchem International Corporation, Kyowa Hakko Bio Co., Ltd., Fuerst Day Lawson Ltd., Meihua Holdings Group Co., Ltd., Penta Manufacturing Company, Fufeng Group Company Limited, Wuxi Jinghai Amino Acid Co., Ltd., Evonik Industries AG, and Avanscure Lifesciences Private Limited. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update* (with the purchase of an enterprise license)
  • 5 additional Company Profiles, pre- or post-purchase, as a free update.
  • Free Updated Version (once released) with the purchase of an enterprise user license.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Investment Opportunities
  • Upcoming/New Entrant by Regions
  • Technology Trend Analysis
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Volume Market Size and Forecast

Key Market Segments

By Type

  • D-Valine
  • L-Valine

By End-Use Industry

  • Feed Industry
  • Food Industry
  • Pharmaceutical Industry
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • Ajinomoto Co., Inc.
  • Foodchem International Corporation
  • Kyowa Hakko Bio Co., Ltd.
  • Fuerst Day Lawson Ltd.
  • Meihua Holdings Group Co., Ltd.
  • Penta Manufacturing Company
  • Fufeng Group Company Limited
  • Wuxi Jinghai Amino Acid Co., Ltd.
  • Evonik Industries AG
  • Avanscure Lifesciences Private Limited

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: VALINE MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. D-Valine
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. L-Valine
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: VALINE MARKET, BY END-USE INDUSTRY
5.1. Market Overview
5.1.1 Market Size and Forecast, By End-use Industry
5.2. Feed Industry
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Food Industry
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Pharmaceutical Industry
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Others
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: VALINE MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Type
6.2.3. Market Size and Forecast, By End-use Industry
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Valine Market
6.2.5.1. Market Size and Forecast, By Type
6.2.5.2. Market Size and Forecast, By End-use Industry
6.2.6. Canada Valine Market
6.2.6.1. Market Size and Forecast, By Type
6.2.6.2. Market Size and Forecast, By End-use Industry
6.2.7. Mexico Valine Market
6.2.7.1. Market Size and Forecast, By Type
6.2.7.2. Market Size and Forecast, By End-use Industry
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Type
6.3.3. Market Size and Forecast, By End-use Industry
6.3.4. Market Size and Forecast, By Country
6.3.5. France Valine Market
6.3.5.1. Market Size and Forecast, By Type
6.3.5.2. Market Size and Forecast, By End-use Industry
6.3.6. Germany Valine Market
6.3.6.1. Market Size and Forecast, By Type
6.3.6.2. Market Size and Forecast, By End-use Industry
6.3.7. Italy Valine Market
6.3.7.1. Market Size and Forecast, By Type
6.3.7.2. Market Size and Forecast, By End-use Industry
6.3.8. Spain Valine Market
6.3.8.1. Market Size and Forecast, By Type
6.3.8.2. Market Size and Forecast, By End-use Industry
6.3.9. UK Valine Market
6.3.9.1. Market Size and Forecast, By Type
6.3.9.2. Market Size and Forecast, By End-use Industry
6.3.10. Rest Of Europe Valine Market
6.3.10.1. Market Size and Forecast, By Type
6.3.10.2. Market Size and Forecast, By End-use Industry
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Type
6.4.3. Market Size and Forecast, By End-use Industry
6.4.4. Market Size and Forecast, By Country
6.4.5. China Valine Market
6.4.5.1. Market Size and Forecast, By Type
6.4.5.2. Market Size and Forecast, By End-use Industry
6.4.6. Japan Valine Market
6.4.6.1. Market Size and Forecast, By Type
6.4.6.2. Market Size and Forecast, By End-use Industry
6.4.7. India Valine Market
6.4.7.1. Market Size and Forecast, By Type
6.4.7.2. Market Size and Forecast, By End-use Industry
6.4.8. South Korea Valine Market
6.4.8.1. Market Size and Forecast, By Type
6.4.8.2. Market Size and Forecast, By End-use Industry
6.4.9. Australia Valine Market
6.4.9.1. Market Size and Forecast, By Type
6.4.9.2. Market Size and Forecast, By End-use Industry
6.4.10. Rest of Asia-Pacific Valine Market
6.4.10.1. Market Size and Forecast, By Type
6.4.10.2. Market Size and Forecast, By End-use Industry
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Type
6.5.3. Market Size and Forecast, By End-use Industry
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Valine Market
6.5.5.1. Market Size and Forecast, By Type
6.5.5.2. Market Size and Forecast, By End-use Industry
6.5.6. South Africa Valine Market
6.5.6.1. Market Size and Forecast, By Type
6.5.6.2. Market Size and Forecast, By End-use Industry
6.5.7. Saudi Arabia Valine Market
6.5.7.1. Market Size and Forecast, By Type
6.5.7.2. Market Size and Forecast, By End-use Industry
6.5.8. Rest of LAMEA Valine Market
6.5.8.1. Market Size and Forecast, By Type
6.5.8.2. Market Size and Forecast, By End-use Industry
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Ajinomoto Co., Inc.
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Foodchem International Corporation
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Kyowa Hakko Bio Co., Ltd.
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Fuerst Day Lawson Ltd.
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Meihua Holdings Group Co., Ltd.
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Penta Manufacturing Company
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Fufeng Group Company Limited
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Wuxi Jinghai Amino Acid Co., Ltd.
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Evonik Industries AG
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Avanscure Lifesciences Private Limited
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Valine Market, by Type, 2024 - 2033 ($Million)
Table 2. Valine Market for D-Valine, by Region, 2024 - 2033 ($Million)
Table 3. Valine Market for L-Valine, by Region, 2024 - 2033 ($Million)
Table 4. Global Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 5. Valine Market for Feed Industry, by Region, 2024 - 2033 ($Million)
Table 6. Valine Market for Food Industry, by Region, 2024 - 2033 ($Million)
Table 7. Valine Market for Pharmaceutical Industry, by Region, 2024 - 2033 ($Million)
Table 8. Valine Market for Others, by Region, 2024 - 2033 ($Million)
Table 9. Valine Market, by Region, 2024 - 2033 ($Million)
Table 10. North America Valine Market, by Country, 2024 - 2033 ($Million)
Table 11. North America Valine Market, by Type, 2024 - 2033 ($Million)
Table 12. North America Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 13. U.S. Valine Market, by Type, 2024 - 2033 ($Million)
Table 14. U.S. Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 15. Canada Valine Market, by Type, 2024 - 2033 ($Million)
Table 16. Canada Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 17. Mexico Valine Market, by Type, 2024 - 2033 ($Million)
Table 18. Mexico Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 19. Europe Valine Market, by Country, 2024 - 2033 ($Million)
Table 20. Europe Valine Market, by Type, 2024 - 2033 ($Million)
Table 21. Europe Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 22. France Valine Market, by Type, 2024 - 2033 ($Million)
Table 23. France Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 24. Germany Valine Market, by Type, 2024 - 2033 ($Million)
Table 25. Germany Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 26. Italy Valine Market, by Type, 2024 - 2033 ($Million)
Table 27. Italy Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 28. Spain Valine Market, by Type, 2024 - 2033 ($Million)
Table 29. Spain Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 30. UK Valine Market, by Type, 2024 - 2033 ($Million)
Table 31. UK Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 32. Rest of Europe Valine Market, by Type, 2024 - 2033 ($Million)
Table 33. Rest of Europe Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 34. Asia-Pacific Valine Market, by Country, 2024 - 2033 ($Million)
Table 35. Asia-Pacific Valine Market, by Type, 2024 - 2033 ($Million)
Table 36. Asia-Pacific Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 37. China Valine Market, by Type, 2024 - 2033 ($Million)
Table 38. China Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 39. Japan Valine Market, by Type, 2024 - 2033 ($Million)
Table 40. Japan Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 41. India Valine Market, by Type, 2024 - 2033 ($Million)
Table 42. India Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 43. South Korea Valine Market, by Type, 2024 - 2033 ($Million)
Table 44. South Korea Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 45. Australia Valine Market, by Type, 2024 - 2033 ($Million)
Table 46. Australia Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 47. Rest of Asia-Pacific Valine Market, by Type, 2024 - 2033 ($Million)
Table 48. Rest of Asia-Pacific Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 49. LAMEA Valine Market, by Country, 2024 - 2033 ($Million)
Table 50. LAMEA Valine Market, by Type, 2024 - 2033 ($Million)
Table 51. LAMEA Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 52. Brazil Valine Market, by Type, 2024 - 2033 ($Million)
Table 53. Brazil Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 54. South Africa Valine Market, by Type, 2024 - 2033 ($Million)
Table 55. South Africa Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 56. Saudi Arabia Valine Market, by Type, 2024 - 2033 ($Million)
Table 57. Saudi Arabia Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 58. Rest of LAMEA Valine Market, by Type, 2024 - 2033 ($Million)
Table 59. Rest of LAMEA Valine Market, by End-use Industry, 2024 - 2033 ($Million)
Table 60. Ajinomoto Co. Inc.: Key Executives
Table 61. Ajinomoto Co. Inc.: Company Snapshot
Table 62. Ajinomoto Co. Inc.: Operating Segments
Table 63. Ajinomoto Co. Inc.: Product Portfolio
Table 64. Ajinomoto Co. Inc.: Key Strategic Moves and Developments
Table 65. Foodchem International Corporation: Key Executives
Table 66. Foodchem International Corporation: Company Snapshot
Table 67. Foodchem International Corporation: Operating Segments
Table 68. Foodchem International Corporation: Product Portfolio
Table 69. Foodchem International Corporation: Key Strategic Moves and Developments
Table 70. Kyowa Hakko Bio Co. Ltd.: Key Executives
Table 71. Kyowa Hakko Bio Co. Ltd.: Company Snapshot
Table 72. Kyowa Hakko Bio Co. Ltd.: Operating Segments
Table 73. Kyowa Hakko Bio Co. Ltd.: Product Portfolio
Table 74. Kyowa Hakko Bio Co. Ltd.: Key Strategic Moves and Developments
Table 75. Fuerst Day Lawson Ltd.: Key Executives
Table 76. Fuerst Day Lawson Ltd.: Company Snapshot
Table 77. Fuerst Day Lawson Ltd.: Operating Segments
Table 78. Fuerst Day Lawson Ltd.: Product Portfolio
Table 79. Fuerst Day Lawson Ltd.: Key Strategic Moves and Developments
Table 80. Meihua Holdings Group Co. Ltd.: Key Executives
Table 81. Meihua Holdings Group Co. Ltd.: Company Snapshot
Table 82. Meihua Holdings Group Co. Ltd.: Operating Segments
Table 83. Meihua Holdings Group Co. Ltd.: Product Portfolio
Table 84. Meihua Holdings Group Co. Ltd.: Key Strategic Moves and Developments
Table 85. Penta Manufacturing Company: Key Executives
Table 86. Penta Manufacturing Company: Company Snapshot
Table 87. Penta Manufacturing Company: Operating Segments
Table 88. Penta Manufacturing Company: Product Portfolio
Table 89. Penta Manufacturing Company: Key Strategic Moves and Developments
Table 90. Fufeng Group Company Limited: Key Executives
Table 91. Fufeng Group Company Limited: Company Snapshot
Table 92. Fufeng Group Company Limited: Operating Segments
Table 93. Fufeng Group Company Limited: Product Portfolio
Table 94. Fufeng Group Company Limited: Key Strategic Moves and Developments
Table 95. Wuxi Jinghai Amino Acid Co. Ltd.: Key Executives
Table 96. Wuxi Jinghai Amino Acid Co. Ltd.: Company Snapshot
Table 97. Wuxi Jinghai Amino Acid Co. Ltd.: Operating Segments
Table 98. Wuxi Jinghai Amino Acid Co. Ltd.: Product Portfolio
Table 99. Wuxi Jinghai Amino Acid Co. Ltd.: Key Strategic Moves and Developments
Table 100. Evonik Industries AG: Key Executives
Table 101. Evonik Industries AG: Company Snapshot
Table 102. Evonik Industries AG: Operating Segments
Table 103. Evonik Industries AG: Product Portfolio
Table 104. Evonik Industries AG: Key Strategic Moves and Developments
Table 105. Avanscure Lifesciences Private Limited: Key Executives
Table 106. Avanscure Lifesciences Private Limited: Company Snapshot
Table 107. Avanscure Lifesciences Private Limited: Operating Segments
Table 108. Avanscure Lifesciences Private Limited: Product Portfolio
Table 109. Avanscure Lifesciences Private Limited: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Valine Market, 2024 - 2033
Figure 2. Segmentation of Valine Market, 2024 - 2033
Figure 3. Top Investment Pocket in Valine Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalvaline Market
Figure 10. Global Valine Market Segmentation, by Type
Figure 11. Valine Market for D-Valine, by Country, 2024 - 2033 ($Million)
Figure 12. Valine Market for L-Valine, by Country, 2024 - 2033 ($Million)
Figure 13. Global Valine Market Segmentation, by End-use Industry
Figure 14. Valine Market for Feed Industry, by Country, 2024 - 2033 ($Million)
Figure 15. Valine Market for Food Industry, by Country, 2024 - 2033 ($Million)
Figure 16. Valine Market for Pharmaceutical Industry, by Country, 2024 - 2033 ($Million)
Figure 17. Valine Market for Others, by Country, 2024 - 2033 ($Million)
Figure 18. Top Winning Strategies, by Year, 2021-2023*
Figure 19. Top Winning Strategies, by Development, 2021-2023*
Figure 20. Top Winning Strategies, by Company, 2021-2023*
Figure 21. Product Mapping of Top 10 Players
Figure 22. Competitive Dashboard
Figure 23. Competitive Heatmap: Valine Market
Figure 24. Top Player Positioning, 2023
Figure 25. Ajinomoto Co. Inc.: Net Sales, 2021-2023 ($Million)
Figure 26. Ajinomoto Co. Inc.: Revenue Share, by Segment, 2023 (%)
Figure 27. Ajinomoto Co. Inc.: Revenue Share, by Region, 2023 (%)
Figure 28. Foodchem International Corporation: Net Sales, 2021-2023 ($Million)
Figure 29. Foodchem International Corporation: Revenue Share, by Segment, 2023 (%)
Figure 30. Foodchem International Corporation: Revenue Share, by Region, 2023 (%)
Figure 31. Kyowa Hakko Bio Co. Ltd.: Net Sales, 2021-2023 ($Million)
Figure 32. Kyowa Hakko Bio Co. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 33. Kyowa Hakko Bio Co. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 34. Fuerst Day Lawson Ltd.: Net Sales, 2021-2023 ($Million)
Figure 35. Fuerst Day Lawson Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 36. Fuerst Day Lawson Ltd.: Revenue Share, by Region, 2023 (%)
Figure 37. Meihua Holdings Group Co. Ltd.: Net Sales, 2021-2023 ($Million)
Figure 38. Meihua Holdings Group Co. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 39. Meihua Holdings Group Co. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 40. Penta Manufacturing Company: Net Sales, 2021-2023 ($Million)
Figure 41. Penta Manufacturing Company: Revenue Share, by Segment, 2023 (%)
Figure 42. Penta Manufacturing Company: Revenue Share, by Region, 2023 (%)
Figure 43. Fufeng Group Company Limited: Net Sales, 2021-2023 ($Million)
Figure 44. Fufeng Group Company Limited: Revenue Share, by Segment, 2023 (%)
Figure 45. Fufeng Group Company Limited: Revenue Share, by Region, 2023 (%)
Figure 46. Wuxi Jinghai Amino Acid Co. Ltd.: Net Sales, 2021-2023 ($Million)
Figure 47. Wuxi Jinghai Amino Acid Co. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 48. Wuxi Jinghai Amino Acid Co. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 49. Evonik Industries AG: Net Sales, 2021-2023 ($Million)
Figure 50. Evonik Industries AG: Revenue Share, by Segment, 2023 (%)
Figure 51. Evonik Industries AG: Revenue Share, by Region, 2023 (%)
Figure 52. Avanscure Lifesciences Private Limited: Net Sales, 2021-2023 ($Million)
Figure 53. Avanscure Lifesciences Private Limited: Revenue Share, by Segment, 2023 (%)
Figure 54. Avanscure Lifesciences Private Limited: Revenue Share, by Region, 2023 (%)

Companies Mentioned

  • Ajinomoto Co., Inc.
  • Foodchem International Corporation
  • Kyowa Hakko Bio Co., Ltd.
  • Fuerst Day Lawson Ltd.
  • Meihua Holdings Group Co., Ltd.
  • Penta Manufacturing Company
  • Fufeng Group Company Limited
  • Wuxi Jinghai Amino Acid Co., Ltd.
  • Evonik Industries AG
  • Avanscure Lifesciences Private Limited

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information